Cargando…

Antagonism of Bradykinin B2 Receptor Prevents Inflammatory Responses in Human Endothelial Cells by Quenching the NF-kB Pathway Activation

BACKGROUND: Bradykinin (BK) induces angiogenesis by promoting vessel permeability, growth and remodeling. This study aimed to demonstrate that the B2R antagonist, fasitibant, inhibits the BK pro-angiogenic effects. METHODOLOGY: We assesed the ability of fasibitant to antagonize the BK stimulation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terzuoli, Erika, Meini, Stefania, Cucchi, Paola, Catalani, Claudio, Cialdai, Cecilia, Maggi, Carlo Alberto, Giachetti, Antonio, Ziche, Marina, Donnini, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879294/ https://www.ncbi.nlm.nih.gov/pubmed/24392129 http://dx.doi.org/10.1371/journal.pone.0084358

Ejemplares similares

Involvement of Bradykinin B2 Receptor in Pathological Vascularization in Oxygen-Induced Retinopathy in Mice and Rabbit Cornea
por: Terzuoli, Erika, et al.
Publicado: (2018)

Bradykinin B2 Receptor Contributes to Inflammatory Responses in Human Endothelial Cells by the Transactivation of the Fibroblast Growth Factor Receptor FGFR-1
por: Terzuoli, Erika, et al.
Publicado: (2018)

Inhibition of cell cycle progression by the hydroxytyrosol–cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells
por: Terzuoli, Erika, et al.
Publicado: (2017)

Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
por: Ciccone, Valerio, et al.
Publicado: (2018)

Correction to: Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
por: Ciccone, Valerio, et al.
Publicado: (2019)

ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence Properties
por: Nannelli, G., et al.
Publicado: (2018)

ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output
por: Terzuoli, Erika, et al.
Publicado: (2019)

mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity
por: Finetti, Federica, et al.
Publicado: (2015)

Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and −186 expression: Novel mechanism of VEGF modulation in prostate cancer
por: Terzuoli, Erika, et al.
Publicado: (2016)

Monitoring Endothelial and Tissue Responses to Cobalt Ferrite Nanoparticles and Hybrid Hydrogels
por: Finetti, Federica, et al.
Publicado: (2016)

Pharmacological Inhibition of Microsomal Prostaglandin E Synthase-1 Suppresses Epidermal Growth Factor Receptor-Mediated Tumor Growth and Angiogenesis
por: Finetti, Federica, et al.
Publicado: (2012)

Nociceptive tolerance is improved by bradykinin receptor B1 antagonism and joint morphology is protected by both endothelin type A and bradykinin receptor B1 antagonism in a surgical model of osteoarthritis
por: Kaufman, Gabriel N, et al.
Publicado: (2011)

NF-kB and the CLL microenvironment
por: O’Donnell, Alice, et al.
Publicado: (2023)

Correction: Bradykinin B1 Receptor Antagonism Is Beneficial in Renal Ischemia-Reperfusion Injury
por: Wang, Pamella H. M., et al.
Publicado: (2008)

ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL-8/Notch signaling cascade
por: Ciccone, Valerio, et al.
Publicado: (2022)

Dengue virus NS5 degrades ERC1 during infection to antagonize NF-kB activation
por: Gonzalez Lopez Ledesma, María Mora, et al.
Publicado: (2023)

PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells
por: Bazzani, Lorenzo, et al.
Publicado: (2018)

The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR Rats
por: Deres, Laszlo, et al.
Publicado: (2019)

Involvement of bradykinin and bradykinin B1 receptor in patients with endometriosis
por: Meng, Xin, et al.
Publicado: (2021)

IκBα beyond the NF-kB dogma
por: Mulero, Maria Carmen, et al.
Publicado: (2013)

Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
por: Riedl, Marc
Publicado: (2010)

NF-kB inhibitor blocks B cell development at two checkpoints
por: Feng, Biao, et al.
Publicado: (2004)

Shocking effects of endothelial bradykinin B1 receptors
por: Luft, Friedrich C.
Publicado: (2008)

NF-kB Expression in IgA Nephropathy Outcome
por: Silva, G. E. B., et al.
Publicado: (2011)

NF-kB pathway is involved in microscopic colitis pathogenesis
por: Pisani, Laura Francesca, et al.
Publicado: (2022)

Use of Nutraceuticals in Angiogenesis-Dependent Disorders
por: Morbidelli, Lucia, et al.
Publicado: (2018)

Characterization of NF-kB-mediated inhibition of catechol-O-methyltransferase
por: Tchivileva, Inna E, et al.
Publicado: (2009)

The SUMOylation machinery is dispensable for Tax-induced NF-kB activation
por: Pène, Sabrina, et al.
Publicado: (2014)

Diisononyl phthalate aggravates allergic dermatitis by activation of NF-kB
por: Kang, Jun, et al.
Publicado: (2016)

NF‐kB signaling in cardiomyocytes is inhibited by sevoflurane and promoted by propofol
por: Oda‐Kawashima, Keiko, et al.
Publicado: (2020)

The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease
por: Sun, Emily, et al.
Publicado: (2022)

Coilin as a regulator of NF-kB mediated inflammation in preeclampsia
por: Logan, Madelyn K., et al.
Publicado: (2022)

The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2020)

Activation of NF-kB pathway in Duchenne muscular dystrophy: relation to age
por: MESSINA, S., et al.
Publicado: (2011)

Activation of NF-kB Pathway by Virus Infection Requires Rb Expression
por: Garcia, Maria A., et al.
Publicado: (2009)

COVID-19 and NF-kB: The Hepcidin paradox and the Iron Storm - reply
por: Banchini, Filippo
Publicado: (2020)

Role of NF-kB RelB in Aryl Hydrocarbon Receptor-Mediated Ligand Specific Effects
por: Ishihara, Yasuhiro, et al.
Publicado: (2019)

Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents
por: Morbidelli, Lucia, et al.
Publicado: (2016)

Bradykinin B(2) receptor blockade and intradialytic hypotension
por: Gamboa, Jorge L., et al.
Publicado: (2023)

Inducible HSP70 Antagonizes IL-1β Cytocidal Effects through Inhibiting NF-kB Activation via Destabilizing TAK1 in HeLa Cells
por: Cao, Xiang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uis4nnhi7n17m0j1rhlrvk0do6